
A stepwise approach can be best. Here are seven rules to follow.

A stepwise approach can be best. Here are seven rules to follow.

A Mayo Clinic study has surprising findings about how controlled substance agreements impact patients on long-term opioid therapy.

Executives from diagnostics, payer, pharma, and patient care companies recently got together to share stakeholder insights on outcomes-based contracting.

Home-based palliative care helps ACOs manage fast-growing senior population with a serious or advanced illness, provide quality care, and generate cost savings that enable ongoing participation in the Medicare Shared Savings Program.

If all consumers had a high understanding of how to navigate the healthcare system, health insurers could save billions of dollars a year. Here ’s what you should do.

Making medications more affordable to patients is linked to better adherence, with no added costs, according to a new study.

Plenty of M&A deals look great on paper but ultimately fall apart in the post-deal integration phase. Here are the biggest pitfalls healthcare executives and stakeholders on both sides of a deal need to consider when managing this critical phase of the process.

New Accenture research reveals how artificial intelligence can net health insurers big bucks.


Eastern Maine Healthcare System’s program helps up-and-coming leaders gain the skills to best situate the healthcare organization for future success


New research from Prophet shares five key shifts healthcare organizations can make in the move toward consumer-centricity.

A new survey has shocking results about consumer knowledge of health insurance.

How healthcare executives can ensure they are always in the best position to take advantage of the next career opportunity.

From EHRs that didn’t fulfill promised savings to a system that still rewards volume over value, our experts examine what’s next in the quest to cut the fat from healthcare spending.

Managed Healthcare Executive asked key opinion leaders their thoughts on the drug rebate controversy. Here’s what they said.

Artificial intelligence is about to do what we hoped to see technology do in the last decade for the health industry: Empower organizations and clinicians to improve the health, outcomes, and experience of care for more people in less time and at lower cost.

The 30-year old regulation is in desperate need of modernization to fall in line with the changing needs of healthcare.


Annual Health Care CEO Survey sheds light on the areas of extreme interest to hospital and health system executives. The results may surprise you.

A Quest Diagnostics survey has surprising results about perceptions of physicians and health plan executives on progress toward value-based healthcare.

Drug costs are increasing, but so is patient cost sharing. That’s raising serious problems for some patients. Here are seven of the most out-of-reach drugs due to high costs, according to industry watchers.

A new study reveals what has happened in several areas of healthcare delivery following the ACA Medicaid expansion.


Many healthcare organizations are expanding leadership roles to help meet business and patient-centered goals.